Cytoreductive surgery and hyperthermic chemoperfusion of the pleural cavity in a child with desmoplastic small round cell tumor. The first Russian experience

Cover Page

Cite item

Full Text

Abstract

Desmoplastic small round cell tumor is a rare and aggressive malignant tumor. The abdominal cavity is the most frequent site of this tumor, but rarely it affects the pleural cavity. This article presents a clinical case of a 10-year-old male with a desmoplastic small round cell tumor of the pleural cavity. Here we describe the first experience of hyperthermic intrapleural chemoperfusion in a pediatric patient in Russia. The patients' parents gave their consent to the use of their children's data, including photographs, for research purposes and in publications.

About the authors

D. G. Akhaladze

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: d.g.akhaladze@gmail.com
ORCID iD: 0000-0002-1387-209X

Dmitry G. Akhaladze, Dr. Med. Sci., Head of Thoracoabdominal Surgery Group

117997, Moscow, Samory Mashela St., 1

Russian Federation

D. Yu. Kachanov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-3704-8783

Moscow

Russian Federation

D. N. Pogorelov

Regional Children's Hospital of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-9331-5049

Lipetsk

Russian Federation

N. G. Uskova

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0001-9424-1646

Moscow

Russian Federation

G. S. Rabaev

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-5691-2522

Moscow

Russian Federation

A. A. Krivonosov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-2636-0675

Moscow

Russian Federation

N. N. Merkulov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0003-0404-6420

Moscow

Russian Federation

S. R. Talypov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-5308-6544

Moscow

Russian Federation

I. V. Tverdov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0001-5150-1436

Moscow

Russian Federation

N. S. Grachev

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-4451-3233

Moscow

Russian Federation

References

  1. Tsuyoshi H., Inoue D., Kurokawa T., Yoshida Y. Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer. J Obstet Gynaecol Res 2020; 46: 1661–71. doi: 10.1111/jog.14391
  2. Klempner S.J., Ryan D.P. HIPEC for colorectal peritoneal metastases. Lancet Oncol 2021; 22 (2): 162–4. doi: 10.1016/S1470-2045(20)30693-8
  3. Liu L., Zhang N., Min J., Su H., Wang H., Chen D., et al. Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC). Oncotarget 2016; 7: 21570–8. doi: 10.18632/oncotarget.7622
  4. Yellin A., Simansky D.A., Paley M., Refaely Y. Hyperthermic pleural perfusion with cisplatin: early clinical experience. Cancer 2001; 92: 2197–203. doi: 10.1002/1097-0142(20011015)92:8<2197::aid-cncr1563>3.0.co;2-f
  5. Zhou H., Wu W., Tang X., Zhou J., Shen Y. Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis. Medicine 2017; 96: e5532. doi: 10.1097/MD.0000000000005532
  6. Honoré C., Atallah V., Mir O., Orbach D., Ferron G., LePéchoux C., et al. Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? PLoS One 2017; 12: e0171639. doi: 10.1371/journal.pone.0171639
  7. Sugarbaker P.H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43 Suppl: S15–25. doi: 10.1007/s002800051093
  8. Jayakrishnan T., Moll R., Sandhu A., Sanguino A., Kaur G., Mao S. Desmoplastic Small Round-cell Tumor: Retrospective Review of Institutional Data and Literature Review. Anticancer Res 2021; 41: 3859–66. doi: 10.21873/anticanres.15179
  9. Raizada N., Daga M.K., Sinha N., Kumar R., Nayak H., Kamble N.L., et al. A rapidly developing lung mass diagnosed as desmoplastic small round cell tumor. Lung India 2011; 28: 287–90. doi: 10.4103/0970-2113.85692
  10. Hayes-Jordan A., LaQuaglia M.P., Modak S. Management of desmoplastic small round cell tumor. Semin Pediatr Surg 2016; 25: 299–304. doi: 10.1053/j.sempedsurg.2016.09.005
  11. Dufresne A., Cassier P., Couraud L., Marec-Bérard P., Meeus P., Alberti L., et al. Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings. Sarcoma 2012; 2012: 714986. doi: 10.1155/2012/714986
  12. Hayes-Jordan A., Green H., Fitzgerald N., Xiao L., Anderson P. Novel treatment for desmoplastic small round cell tumor: hyperthermic intraperitoneal perfusion. J Pediatr Surg 2010; 45 (5): 1000–6. doi: 10.1016/j.jpedsurg.2010.02.034
  13. Jin D., Chen M., Wang B., Gou Y. Mediastinal desmoplastic small round cell tumor. Medicine 2020; 99: e22921. doi: 10.1097/MD.0000000000022921
  14. Jellouli M., Mekki M., Krichene I., Zakhama A., Belghith M., Jouini R., et al. Intra-abdominal desmoplastic small round cell tumor in childhood: case report and review of the literature. Bull Cancer 2003; 90: 1063–6.
  15. Петрикова Н.И., Ефременков A.M., Сниткин Н.A., Трунова Р.Б., Бурлуцкая T.И. Десмопластическая мелкокруглоклеточная опухоль у ребенка. Онкопедиатрия 2016; 3: 42–7. doi: 10.15690/onco.v3i1.1528
  16. Kushner B.H., LaQuaglia M.P., Wollner N., Meyers P.A., Lindsley K.L., Ghavimi F., et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol 1996; 14 (5): 1526–31. doi: 10.1200/jco.1996.14.5.1526
  17. Fois A.G., Pirina P., Arcadu A., Becciu F., Manca S., Marras V., et al. Desmoplastic small round cell tumors of the pleura: a review of the clinical literature. Multidiscip Respir Med 2017; 12: 22. doi: 10.1186/s40248-017-0103-6
  18. Spratt J.S., Adcock R.A., Sherrill W., Travathen S. Hyperthermic peritoneal perfusion system in canines. Cancer Res 1980; 40: 253–5.
  19. Baronzio G., Schwartz L., Kiselevsky M., Guais A., Sanders E., Milanesi G., et al. Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis. Anticancer Res 2012; 32: 405–14.
  20. Ахаладзе Д.Г., Рабаев Г.С., Грачев Н.С. Циторедуктивные операции и внутрибрюшная гипертермическая химиоперфузия у детей. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2019; 18 (4): 118‒26. doi: 10.24287/1726-1708-2019-18-4-118-126
  21. Howell S.B., Pfeifle C.L., Wung W.E., Olshen R.A., Lucas W.E., Yon J.L., et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982; 97: 845–51. doi: 10.7326/0003-4819-97-6-845
  22. Himmelstein K.J., Patton T.F., Belt R.J., Taylor S., Repta A.J., Sternson L.A. Clinical kinetics on intact cisplatin and some related species. Clin Pharmacol Ther 1981; 29: 658–64. doi: 10.1038/clpt.1981.91
  23. Ried M., Eichhorn M., Winter H., Grützner U., Lindner M., Hatz R.A., et al. Expert Recommendation for the Implementation of Hyperthermic Intrathoracic Chemotherapy (HITOC) in Germany. Zentralbl Chir 2020; 145: 89–98. doi: 10.1055/a-0934-7806
  24. Glehen O., Mohamed F., Sugarbaker P.H. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 2004; 240: 278–85. doi: 10.1097/01.sla.0000133183.15705.71
  25. Dayal S., Taflampas P., Riss S., Chandrakumaran K., Cecil T.D., Mohamed F., et al. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum 2013; 56: 1366–72. doi: 10.1097/DCR.0b013e3182a62b0d
  26. [Internet] PROMISE – Welcome to PROMISE evaluation. URL: https://www.e-promise.org. (Date of access to the source 10.11.2022).
  27. Ахаладзе Д.Г., Рабаев Г.С., Грачев Н.С. Технические особенности циторедуктивных операций и внутрибрюшной гипертермической химиоперфузии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2020; 19 (4): 224–33. doi: 10.24287/1726-1708-2020-19-4-224-233
  28. Da Silva R.G., Sugarbaker P.H. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 2006; 203: 878–86. doi: 10.1016/j.jamcollsurg.2006.08.024

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Akhaladze D.G., Kachanov D.Y., Pogorelov D.N., Uskova N.G., Rabaev G.S., Krivonosov A.A., Merkulov N.N., Talypov S.R., Tverdov I.V., Grachev N.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.